Active

GALEPHAR M/F

Switched

BE0464786485

Rechtspersoon Public limited company 1 establishment

Marche, Rue du Parc Industriel 39, 6900 Marche-en-Famenne Vervaardiging van geneesmiddelen

Active for

27 year, 8 months

Financials

Financial year 2025

Revenue

€ 10.8 million

▲ 99% vs 2024

Profit

Growing

€ 3.6 million

▲ 714% vs 2024

Debts

Low

€ 2 million

▲ 130% vs 2024

GALEPHAR M/F from Marche-en-Famenne, company number BE0464786485, closed financial year 2025 with a result of € 3.6 million after tax. For that financial year GALEPHAR M/F recorded revenue of € 10.8 million and equity of € 19.6 million. Compared with financial year 2024, the result moved from € 446,781 to € 3.6 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 22, 2026.

What happened at GALEPHAR M/F?

What happened at GALEPHAR M/F in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • FRANCOIS BAUDIER stepped down as director. NBB
  • ARTHUR DEBOECK stepped down as director. NBB
  • New annual accounts for financial year 2025: profit of € 3.6 million (▲ 714% vs 2024). Source: NBB ↗
  • FRANCOIS BAUDIER became a director. NBB
  • ARTHUR DEBOECK became a director. NBB
  • New establishment in Marche-en-Famenne. KBO
  • Start of the company according to the CBE. KBO

In short

From € 4.4 million profit in 2021 to € 3.6 million profit in 2025.

Paid € 3.4 million in corporate taxes since 2021.

Best year ever: 2021, with € 4.4 million profit.

Paid out € 27 million in dividends to the owners in total.

A new publication or filing at GALEPHAR M/F? We notify you, reason included.

Follow GALEPHAR M/F

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

PHILIPPE BAUDIER
GALEPHAR M/F

The shares are held by PHILIPPE BAUDIER and LABORATOIRES SMB.

See the full network in the app

Directors

According to the 2025 annual accounts

FRANCOIS BAUDIER

Managing director

since 2022 · until 2028

ARTHUR DEBOECK

Director

since 2022 · until 2028

Shareholders

PHILIPPE BAUDIER

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Marche, Rue du Parc Industriel 39

6900 Marche-en-Famenne

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

Details

Company number
0464.786.485
VAT number
BE 0464.786.485
Registered office
Marche, Rue du Parc Industriel 39, 6900 Marche-en-Famenne
Names & denominations
GALEPHAR M/F
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
24 December 1998
Peppol
Active · Active since 27 Mar 2026
Activities · NACE

Vervaardiging van geneesmiddelen

Activiteiten van medische beeldvorming en medische laboratoria

Medische laboratoria

Activiteiten van medische laboratoria

Frequently asked questions

What is the enterprise number of GALEPHAR M/F?
The enterprise number of GALEPHAR M/F is BE0464786485.
What is the address of GALEPHAR M/F?
The registered office of GALEPHAR M/F is located at Marche, Rue du Parc Industriel 39, 6900 Marche-en-Famenne.
When was GALEPHAR M/F founded?
GALEPHAR M/F was founded on 24 December 1998.
What is the main activity of GALEPHAR M/F?
The main activity of GALEPHAR M/F is "Vervaardiging van geneesmiddelen" (NACE code 21201).
Does GALEPHAR M/F have a website?
No website is currently known for GALEPHAR M/F.
How much profit did GALEPHAR M/F make in 2025?
GALEPHAR M/F posted a profit after taxes of € 3,638,239 in financial year 2025.
What is the revenue of GALEPHAR M/F?
In its most recent annual accounts (2025), GALEPHAR M/F reported revenue of € 10,790,855.
How many employees does GALEPHAR M/F have?
According to the 2025 annual accounts, GALEPHAR M/F has 38.8 full-time equivalents (FTE).
Where can I find the annual accounts of GALEPHAR M/F?
GALEPHAR M/F files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of GALEPHAR M/F?
According to the 2025 annual accounts, the directors of GALEPHAR M/F are: FRANCOIS BAUDIER, ARTHUR DEBOECK.
Who owns GALEPHAR M/F?
The shares are held by PHILIPPE BAUDIER and LABORATOIRES SMB.
Who are the shareholders of GALEPHAR M/F?
According to the 2025 annual accounts, the shareholders of GALEPHAR M/F are: PHILIPPE BAUDIER, LABORATOIRES SMB.